• LOGIN
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publication
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Synchrotron Microbeam Radiotherapy in combination with gold nanoparticles improves control of mouse melanoma.
 

Synchrotron Microbeam Radiotherapy in combination with gold nanoparticles improves control of mouse melanoma.

Options
  • Details
BORIS DOI
10.48620/90572
Date of Publication
July 30, 2025
Publication Type
Article
Division/Institute

Institute of Anatomy

Institute of Anatomy,...

Institut für Anatomie...

Author
Fernandez-Palomo, Cristianorcid-logo
Institute of Anatomy, Topographical and Clinical Anatomy
Institute of Anatomy
Potez, Marine
Haberthür, Davidorcid-logo
Institut für Anatomie - MicroCT
Institute of Anatomy, Topographical and Clinical Anatomy
Trappetti, Verdianaorcid-logo
Institute of Anatomy, Topographical and Clinical Anatomy
Institute of Anatomy
Pellicioli, Paoloorcid-logo
Institute of Anatomy, Topographical and Clinical Anatomy
Fazzari, Jennifer
Grams, Michael
Hlushchuk, Ruslan
Institut für Anatomie - MicroCT
Institute of Anatomy, Topographical and Clinical Anatomy
Djonov, Valentinorcid-logo
Institute of Anatomy, Topographical and Clinical Anatomy
Institute of Anatomy
Series
International Journal of Radiation Oncology - Biology - Physics
ISSN or ISBN (if monograph)
1879-355X
0360-3016
Publisher
Elsevier
Language
English
Publisher DOI
10.1016/j.ijrobp.2025.07.1427
PubMed ID
40749779
Uncontrolled Keywords

Drug delivery

Microbeam radiation t...

Mouse Melanoma

Spatially Fractionate...

Vascular Permeability...

gold nanoparticles

Description
Introduction
Microbeam Radiation Therapy (MRT) is a preclinical, spatially fractionated radiotherapy technique that delivers ultra-narrow synchrotron x-ray beams at ultra-high dose rates. MRT has demonstrated superior tumor control compared to synchrotron Broad Beam by triggering infiltration of CD8+ T cells and inducing a transient vascular permeability window. This study aimed to investigate the effects of combining MRT with Gold Nanoparticles (AuNPs) on tumor growth, while also assessing whether MRT could enhance intra-tumoral accumulation of AuNPs.Methods
Mice bearing B16-F10 melanoma in their ears were assigned to seven experimental groups, each receiving distinct combinations of priming MRT (150Gy peak-dose), AuNPs, Broad Beam (6.1Gy), and therapeutic MRT (400Gy peak-dose). MRT was delivered as an array of 50µm-wide beams spaced 200µm apart. Tumor growth was monitored daily, while 15nm AuNP uptake was assessed with microCT imaging, electron microscopy, and Image Mass Cytometry.Results
Priming MRT increased intra-tumoral AuNP accumulation by 2.5-fold on day 3 and 2.3-fold on day 5 compared to non-primed controls. Image Mass Cytometry showed that AuNPs distributed across the tumor stroma and concentrated at the tumor periphery, near areas with high vascular density and in M2-like macrophages. Combining priming MRT with AuNPs and therapeutic MRT achieved the best tumor growth delay and regression with a median survival to 39.5 days; significantly longer than the 17 days achieved with priming MRT, AuNPs, and broad beam. The sensitizer enhancement ratio of 1.38 highlighted the efficacy of AuNP-enhanced MRT.Conclusion
Our study introduces a novel approach in cancer therapy, demonstrating that MRT serves as both a potent standalone treatment and an effective enhancer of drug delivery. MRT increased the tumoral concentration of AuNPs and could potentially do the same with other therapeutic agents. Our findings strongly advocate for the continued development of MRT-based combination regimens and highlight the clinical potential of this dual-mechanism approach.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/214502
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
1-s2.0-S0360301625060250-main.pdftextAdobe PDF1.35 MBAttribution-NonCommercial-NoDerivatives (CC BY-NC-ND 4.0)accepted embargo
BORIS Portal
Bern Open Repository and Information System
Build: d1c7f7 [27.06. 13:56]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo